# A Study to Investigate the Tolerability and Safety of Converting Stable Renal Transplant Recipients Who Receive Tacrolimus With or Without Corticosteroids From Mycophenolate Mofetil (MMF) to Enteric-coated Mycophenolate Sodium (EC-MPS)

> **NCT00238979** · PHASE4 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 50 (—)

## Conditions studied

- Renal Transplantation

## Interventions

- **DRUG:** Enteric-Coated Mycophenolate Sodium (EC-MPS)

## Key facts

- **NCT ID:** NCT00238979
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-01
- **Primary completion:** 2005-02
- **Final completion:** —
- **Target enrollment:** 50 (—)
- **Last updated:** 2011-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00238979

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00238979, "A Study to Investigate the Tolerability and Safety of Converting Stable Renal Transplant Recipients Who Receive Tacrolimus With or Without Corticosteroids From Mycophenolate Mofetil (MMF) to Enteric-coated Mycophenolate Sodium (EC-MPS)". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00238979. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*